The caller alleged a variance between inratio inr results and comparison to the lab inr results.The results were as follows: (b)(6): inratio=2.2, (b)(6): inratio=>7.5, lab=5.7, (b)(6): inratio=7.2, lab=5.3.The patient's therapeutic range: unknown.Multiple drops of blood were added when testing.No medication or diet changes between (b)(6) inratio=2.2 and (b)(6) inratio=: >7.5 results.Coumadin, 1.5mg/day; held for 2 days after 5.7 lab result on (b)(6); resumed on (b)(6).
|
It is indicated that product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.Retain strip testing results met both accuracy and repeatability criteria.The product performed as expected and no product deficiencies were observed.The release specification is within the calculated confidence interval of the percent flier rate for complaint investigation testing.A review of the manufacturing records indicated that the lot met release specification.Although an improper technique was identified, a root cause could not be determined without additional information.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|